Show simple item record

dc.contributor.authorBrant, Cesar Quintao [UNIFESP]
dc.contributor.authorNakao, Frank Shigueo [UNIFESP]
dc.contributor.authorArdengh, Jose Celso [UNIFESP]
dc.contributor.authorNasi, Ary [UNIFESP]
dc.contributor.authorFerrari, Angelo Paulo [UNIFESP]
dc.date.accessioned2018-06-15T17:17:24Z
dc.date.available2018-06-15T17:17:24Z
dc.date.issued1999-01-01
dc.identifierhttp://dx.doi.org/10.1046/j.1442-2050.1999.00002.x
dc.identifier.citationDiseases Of The Esophagus. Carlton: Blackwell Science Asia, v. 12, n. 1, p. 37-40, 1999.
dc.identifier.issn1120-8694
dc.identifier.urihttp://repositorio.unifesp.br/11600/43496
dc.description.abstractBotulinum toxin (BT) has recently been indicated as an alternative treatment of idiopathic achalasia with a success rate of 60-70%, One-third of BT-treated cases either fail to respond or fail to sustain the response beyond 6 months. An explanation for BT therapeutic failure would be that the lower esophageal sphincter muscular layer (LES) may be missed as injection is delivered 'blindly'. We aimed to evaluate the percentage of exact endoscopically 'blind' LES punctures using echoendoscopy after the injection of BT for the treatment of Chagas' achalasia (CA), Five patients with CA (mean age 53 years) were randomized to receive 1.2 mi of BT or the same amount of saline injected endoscopically. Echoendoscopy was performed immediately after puncture. Patients Here evaluated by the clinical score of dysphagia, radiological examination, upper endoscopy and esophageal manometry and followed up for 6 months. All puncture sites were identified: 17 out of 20 (85%) in the muscle layer and 3 out of 20 (15%) in the submucosa, The three patients in the treatment group showed clinical improvement (average clinical score fell from 14 to 2 after 7 days, and remained at 4 after 6 months of follow-up), The mean pressure of the LES dropped by 29%, Neither patient in the placebo group showed clinical improvement, and the mean pressure of the LES increased by 35%,Endoscopic 'blind' injection of BT into the LES through endoscopy for the management of achalasia is a safe and reproducible technique and has a high percentage of exactness.en
dc.format.extent37-40
dc.language.isoeng
dc.publisherBlackwell Science Asia
dc.relation.ispartofDiseases Of The Esophagus
dc.rightsAcesso restrito
dc.titleEchoendoscopic evaluation of botulinum toxin intrasphincteric injections in Chagas' disease achalasiaen
dc.typeArtigo
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.description.affiliationUniv Fed Sao Paulo, Div Gastroenterol, Sao Paulo, Brazil
dc.description.affiliationUnifespUniv Fed Sao Paulo, Div Gastroenterol, Sao Paulo, Brazil
dc.identifier.doi10.1046/j.1442-2050.1999.00002.x
dc.description.sourceWeb of Science
dc.identifier.wosWOS:000083699500008


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record